Skip to content

Effect of the Coughing Technique During Subcutaneous Heparin Injection

Effect of the Coughing Technique During Subcutaneous Heparin Injection on Pain Severity and Individual Satisfaction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05681338
Enrollment
60
Registered
2023-01-12
Start date
2022-03-17
Completion date
2022-06-30
Last updated
2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystectomy, Colon Surgery, Inguinal Hernia, Thyroidectomy

Keywords

subcutaneous heparin injection, coughing technique, pain, individual satisfaction, non-pharmacological method

Brief summary

Objective: to examine the effect of the medium intensity coughing technique during subcutaneous low molecular weight heparin injection on pain severity and individual satisfaction in general surgery patients. Method: a prospective, quasi-experimental study included 100 patients who had prescribed a subcutaneous low molecular weight heparin injection once in 24 hours. Each patient received two injections by the same researcher using standard injection technique with medium intensity coughing technique and only standard injection technique.

Detailed description

Aims and objectives: The aim of this study was to examine the effect on the level of pain severity and satisfaction of patients of the medium intensity coughing technique applied to patients during the administration of subcutaneous low molecular weight heparin (LMWH) injection. Design: This research was a prospective quasi-experimental study. Methods: It was conducted with 100 patients in the General Surgery Clinic of a university hospital in the Marmara Region of Turkey. Subcutaneous LMWH injections were administered by the same nurse to the outer side of the right and left upper arms by the standard injection technique and the medium intensity coughing technique. Immediately after the subcutaneous LMWH injection was given, a researcher who did not know which injection method had been used asked the patients to evaluate their pain levels by the Visual Analog Scale (VAS) and their satisfaction with the performance of the injection by the Visual Individual Satisfaction Scale (VISS).

Interventions

OTHERthe medium intensity coughing technique

The medium intensity coughing technique: Immediately before the subcutaneous LMWH injection was given, patients were asked to cough twice at a medium level. After that, they were asked to cough ten seconds later for a second time at the same level, and while they were coughing for the second time, the needle was inserted into the tissue.

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

The measurements were carried out by the first researcher.

Eligibility

Sex/Gender
ALL
Age
22 Years to 86 Years
Healthy volunteers
No

Inclusion criteria

* Participating voluntarily in the study * Being over the age of 18, * Having a doctor's prescription for subcutaneous low molecular weight heparin 0.6 mL treatment and not yet having begun treatment. * Having no coagulation disorder, having no disorder that could affect pain perception, - * Having no incision, lipodystrophy, or finding of infection at the injection site, * Having no communication problem

Exclusion criteria

* Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study * Having any condition which would affect the sensation of pain * Not being able to agree on a place or time * Being less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Pain assessed by Visual Analog Scale (VAS)2 monthsIn evaluating the severity of pain felt by the patients during subcutaneous injections, a 10 cm long vertical VAS was used, on which one end represented no pain, and the other end the worst possible pain. The VAS is a commonly used pain assessment scale in clinical settings. Pain severity measurements were evaluated in millimeters.
Satisfaction assessed by the Visual Individual Satisfaction Scale (VISS)2 monthsDuring the administration of the injection, an evaluation was made to determine individuals' satisfaction using the Visual Individual Satisfaction Scale, which consisted of a vertical 10 cm scale with I'm very satisfied written at one end of it and I'm not at all satisfied at the other. The Visual Individual Satisfaction Scale incorporated the characteristics of the well-known Visual Analog Scale (VAS). Satisfaction level measurements were evaluated in millimeters.

Secondary

MeasureTime frameDescription
Weight2 monthsweight in kilograms
Height2 monthsheight in meters
BMI2 monthsBMI in kg/m\^2

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026